Literature DB >> 10976607

Syringe availability as HIV prevention: a review of modalities.

P Coffin1.   

Abstract

This review examines recent research into modalities for improving access to sterile syringes for injection drug users (IDUs) as a means to reduce human immunodeficiency virus (HIV) transmission. English language studies with empirical data were collected through Uncover reports and MedLine searches from 1998 to 2000. Although syringe-exchange programs are the most established and well-evaluated means of improving access to sterile syringes, research on alternative modalities-such as pharmacy sale, injector-specific packs, mass distribution, and vending machines-and on coverage of special populations suggests the need to pursue multiple avenues of increasing syringe availability simultaneously and, in particular, to explore modalities other than syringe-exchange programs when HIV incidence is under control. The impacts on HIV transmission of cocaine injection and sex with IDUs need to be explored further. Finally, any evidence of declining hepatitis C incidence among young IDUs might serve as a surrogate for a sharp drop in injection-related HIV risk behaviors in that population.

Entities:  

Mesh:

Year:  2000        PMID: 10976607      PMCID: PMC3456039          DOI: 10.1007/BF02386743

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  86 in total

1.  Knowledge about and behaviors affecting the spread of AIDS: a street survey of intravenous drug users and their associates in New York City.

Authors:  P H Kleinman; D S Goldsmith; S R Friedman; W Hopkins; D C Des Jarlais
Journal:  Int J Addict       Date:  1990-04

2.  Deregulation of syringes and needles for medical use and to prevent the spread of blood-borne pathogens among illicit injection drug users.

Authors:  L J Morse
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

3.  Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users.

Authors:  J D Rich; B P Dickinson; K L Liu; P Case; B Jesdale; R M Ingegneri; P A Nolan
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

4.  Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Authors:  L Wright-De Agüero; B Weinstein; T S Jones; J Miles
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

5.  AIDS and the new drug injector.

Authors:  S R Friedman; D C Des Jarlais; A Neaigus; A Abdul-Quader; J L Sotheran; M Sufian; S Tross; D Goldsmith
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

6.  Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.

Authors:  A Peak; S Rana; S H Maharjan; D Jolley; N Crofts
Journal:  AIDS       Date:  1995-09       Impact factor: 4.177

Review 7.  Epidemiology of hepatitis C virus infection among injecting drug users in Australia.

Authors:  N Crofts; D Jolley; J Kaldor; I van Beek; A Wodak
Journal:  J Epidemiol Community Health       Date:  1997-12       Impact factor: 3.710

8.  Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals.

Authors:  R Wyld; J R Robertson; R P Brettle; J Mellor; L Prescott; P Simmonds
Journal:  J Infect       Date:  1997-09       Impact factor: 6.072

9.  A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?

Authors:  E H Kaplan; K Khoshnood; R Heimer
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

Review 10.  Occupational health in surgery: risks extend beyond the operating room.

Authors:  J A Patz; D Jodrey
Journal:  Aust N Z J Surg       Date:  1995-09
View more
  10 in total

1.  What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.

Authors:  S J Klein; K Harris-Valente; A R Candelas; M Radigan; M Narcisse-Pean; J M Tesoriero; G S Birkhead
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

Review 2.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

Review 3.  Updating the infection risk reduction hierarchy: preventing transition into injection.

Authors:  David Vlahov; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Don C Des Jarlais
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

4.  New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.

Authors:  P O Coffin; B P Linas; S H Factor; D Vlahov
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

Review 5.  Reporting quality of search methods in systematic reviews of HIV behavioral interventions (2000-2010): are the searches clearly explained, systematic and reproducible?

Authors:  Mary M Mullins; Julia B DeLuca; Nicole Crepaz; Cynthia M Lyles
Journal:  Res Synth Methods       Date:  2013-10-08       Impact factor: 5.273

6.  Dealing with the long-term social implications of research.

Authors:  Alan Fleischman; Carol Levine; Lisa Eckenwiler; Christine Grady; Dale E Hammerschmidt; Jeremy Sugarman
Journal:  Am J Bioeth       Date:  2011-05       Impact factor: 11.229

7.  Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.

Authors:  Samuel M Jenness; Holly Hagan; Kai-Lih Liu; Travis Wendel; Christopher S Murrill
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

8.  Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes.

Authors:  Nadia Abdala; Amisha Patel; Robert Heimer
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-22       Impact factor: 2.205

Review 9.  Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.

Authors:  Ricardo M Fernandes; Maria Cary; Gonçalo Duarte; Gonçalo Jesus; Joana Alarcão; Carla Torre; Suzete Costa; João Costa; António Vaz Carneiro
Journal:  BMC Public Health       Date:  2017-04-11       Impact factor: 3.295

10.  Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.

Authors:  Paxton Bach; Daniel Hartung
Journal:  Addict Sci Clin Pract       Date:  2019-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.